Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 450 across all filing types
Latest filing 2020-11-18 Regulatory Filings
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Demise
Regulatory Filings Classification · 90% confidence The document text is extremely short (116 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report title, no regulatory references, no meeting or voting information, and no narrative or textual content to classify as a specific report type. Given the lack of content and the absence of any indicators, the document cannot be classified as a full report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2020-11-18 English
Investor Presentation
Regulatory Filings
2020-11-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is a notification about an upcoming conference call scheduled for November 9, 2020, to discuss the Q2 FY21 earnings results of Nath Bio-Genes (India) Limited. It includes dial-in details and contact information but does not contain any financial data or detailed discussion of results itself. The document is short (2380 characters) and serves as an invitation or intimation for the earnings call rather than the call transcript or earnings release. Therefore, it fits best under the category of Call Transcript (CT) invitation or notice. However, since it is only an intimation and not the transcript itself, the closest appropriate classification is Call Transcript (CT) as it relates directly to the earnings call event.
2020-11-07 English
Outcome of Board Meeting
Regulatory Filings
2020-11-07 English
Financial Result Updates
Regulatory Filings
2020-11-07 English
Board Meeting — Financial Results
Regulatory Filings
2020-10-29 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.